Pricing Log in Create free account

Cadrenal Therapeutics, Inc. (CVKD) vs Onconetix, Inc. (ONCO)

Cadrenal Therapeutics, Inc. and Onconetix, Inc. are both Biotechnology companies. Cadrenal Therapeutics, Inc. is the larger, with a market value of $3.6M against $3.2M — 1.1× the size. Cadrenal Therapeutics, Inc. has the higher net margin (0.00% vs −1,578.6%) and the lower return on invested capital (−427.5% vs −135.4%). Across the 13 metrics below, Onconetix, Inc. leads on 7 and Cadrenal Therapeutics, Inc. on 6.

Valuation

Metric CVKD ONCO Biotechnology median
P/E n/m n/m 10.60
P/S n/m 23.65 9.40
P/B 0.74 1.13 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 14.63 9.02
Earnings yield (471.15%) (2,931.13%) (32.88%)
Free cash flow yield (335.44%) (67.68%) (23.13%)

Profitability

Metric CVKD ONCO Biotechnology median
Gross margin 0.00% 80.38% 68.51%
Operating margin 0.00% (2,524.73%) 0.00%
Net margin 0.00% (1,578.60%) 0.00%
Free cash flow margin 0.00% (1,595.90%) 0.00%
Return on equity (275.16%) (105.23%) (51.96%)
Return on assets (199.59%) (57.37%) (46.06%)
Return on invested capital (427.54%) (135.42%) 0.00%

Growth

Metric CVKD ONCO Biotechnology median
Revenue growth (TTM) — (51.33%) 6.76%
EPS growth (last fiscal year) 23.94% 99.09% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CVKD ONCO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.73 2.21 4.97
Net debt to EBITDA 0.30 0.29 1.01

Dividend

Metric CVKD ONCO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CVKD ONCO Biotechnology median
Market cap 3.57m 3.24m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack